期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
地黄饮子调节PERK/elF2α通路抑制能量代谢障碍AD小鼠脑内β淀粉样蛋白累积的作用机制 被引量:11
1
作者 张志辰 温彬宇 +3 位作者 高俊峰 唐旭 黄倩倩 马涛 《中国实验方剂学杂志》 CAS CSCD 北大核心 2018年第21期91-98,共8页
目的:以能量代谢障碍淀粉样前体蛋白(APP)/早老素基因1(PS1)转基因小鼠为阿尔茨海默病(Alzheimer's disease,AD)模型,探讨地黄饮子通过调控蛋白激酶R样内质网激酶(protein kinase r-like endoplasmic reticulum kinase,PERK)... 目的:以能量代谢障碍淀粉样前体蛋白(APP)/早老素基因1(PS1)转基因小鼠为阿尔茨海默病(Alzheimer's disease,AD)模型,探讨地黄饮子通过调控蛋白激酶R样内质网激酶(protein kinase r-like endoplasmic reticulum kinase,PERK),真核细胞起始因子2α(eukaryotic initiation factor 2α,eI F2α)通路抑制内质网应激导致的β-淀粉样蛋白(Aβ)累积的作用机制。方法:4月龄APP/PS1转基因小鼠随机分为正常组、模型组、阳性药(安理申)组、地黄饮子低、中、高剂量组。除正常组小鼠腹腔注射无菌生理盐水外,其余各组小鼠均腹腔注射100 mg·kg-13-硝基丙酸(3-nitropropionic acid,3-NP) 1次。小鼠造模后,立即给药。灌胃给药1周后,Morris水迷宫实验检测小鼠学习记忆能力,高效液相色谱法检测小鼠脑内三磷酸腺苷(ATP),二磷酸腺苷(ADP),一磷酸腺苷(AMP)含量,并计算脑能荷(energy charge,EC)。蛋白免疫印迹法(Western blot)检测小鼠脑内PERK,eI F2α磷酸化水平,β-淀粉样前体蛋白水解酶1(BACE1)表达水平。实时荧光定量聚合酶链式反应(Real-time PCR)检测BACE1 mRNA表达水平。酶联免疫吸附测定法(ELISA)检测小鼠脑内Aβ含量。结果:与正常组比较,Morris水迷宫实验结果显示,在定位巡航实验中,地黄饮子可以明显缩短模型小鼠的逃避潜伏期(P 〈0. 05,P 〈0. 01);空间探索实验中,地黄饮子可以增加模型小鼠穿越目标区域的次数(P 〈0. 05,P 〈0. 01)和在目标象限的停留时间(P 〈0. 01),减少相对象限的停留时间(P 〈0. 05,P 〈0. 01)。地黄饮子可以显著降低AMP水平,明显升高ATP,ADP水平,显著提高模型小鼠脑内EC水平(P 〈0. 05,P 〈0. 01),抑制PERK,eI F2α的磷酸化(P 〈0. 01)和BACE1的蛋白水平(P 〈0. 01),但对BACE1 mRNA转录没有显著影响。地黄饮子能够减少模型小鼠脑内Aβ的含量(P 〈0. 01)。结论:� 展开更多
关键词 地黄饮子 阿尔茨海默病 能量代谢障碍 内质网应激 蛋白激酶r样内质网激酶(protein KINASE r-likeendoplasmic reticulum kinase PErK)/真核细胞起始因子2α(eukaryotic initiation factor eIF2α) β-淀粉样蛋白
原文传递
Tumor necrosis factor a accelerates Hep-2 cells proliferation by suppressing TRPP2 expression 被引量:2
2
作者 Jing Wu Jizheng Guo +6 位作者 Yunyun Yang Feifei Jiang Shuo Chen Kaile Wu Bing Shen Yehai Liu Juan Du 《Science China(Life Sciences)》 SCIE CAS CSCD 2017年第11期1251-1259,共9页
TRPP2, a Ca2+-permeable non-selective cation channel, has been shown to negatively regulate cell cycle, but the mechanism underlying this regulation is unknown. Tumor necrosis factor a (TNF-a) is a proinflammatory ... TRPP2, a Ca2+-permeable non-selective cation channel, has been shown to negatively regulate cell cycle, but the mechanism underlying this regulation is unknown. Tumor necrosis factor a (TNF-a) is a proinflammatory cytokine extensively involved in immune system regulation, cell proliferation and cell survival. However, the effects and mechanisms for the role of TNF-a in laryngeal cancer remain unclear. Here, we demonstrated using western blot analyses and intracellular Ca〉 concentration measurements that TNF-a treatment suppressed both TRPP2 expression and ATP-induced Ca2+ release in a laryngeal cancer cell line (Hep-2). Knockdown of TRPP2 by a specific siRNA significantly decreased ATP-induced Ca2+ release and abolished the effect of TNF-a on the ATP-induced Ca2+ release. TNF-a treatment also enhanced Hep-2 cell proliferation and growth, as determined using cell counting and flow cytometry cell cycle assays. Moreover, TNF-a treatment down-regulated phosphorylated protein kinase R-like endoplasmic reticulum kinase (p-PERK) and phosphorylated eukaryotic translation initiation factor (p-elF2c0 expression levels, without affecting PERK and elF2ct expression levels in Hep-2 cells. We concluded that suppressing TRPP2 expression and TRPP2-mediated Ca2+ signaling may be one mechanism underlying TNF〈t-enhanced Hep-2 cell proliferation. These results offer new insights into the mechanisms of TNF-a-mediated laryngeal cancer cell proliferation, and provide evidences showing a potential role of TNF-a in the development of laryngeal cancer. 展开更多
关键词 tumor necrosis factor a TrPP2 human laryngeal squamous cell carcinoma PrOLIFErATION protein kinase r-likeendoplasmic reticulum kinase eukaryotic translation initiation factor
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部